Harm reduction ‘back on the table’ with Trudeau win

Insite pioneers say government open to more supervised injection services now that the Tories are gone.

A Liberal majority government will open the door for more supervised injection sites across Canada, according to Larry Campbell.

The Liberal senator was Vancouver’s mayor when Insite became the first supervised injection site in North America.

It remains the only facility of its kind (although the Dr. Peter Centre also provides injection services for clients), thanks to Stephen Harper’s repeated failed attempts to shut it down through the courts and legislation making it almost impossible for other cities to adopt a similar model.

But with a clear Justin Trudeau election night victory, the battle between evidence-based harm reduction and ideology is over, said Campbell.

“I think we’ll see harm reduction back on the table,” Campbell told Metro on Tuesday. “Insite wasn’t going anywhere, they won that battle. Two million injections and no deaths, the evidence is there. It’s a win for communities that wanted it as [Conservatives] made it impossible to build supervised injection sites anywhere else.”

Hedy Fry, the re-elected Liberal MP for Vancouver Centre, said her party was a key partner in the Vancouver Agreement that led to Insite.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)